Related references
Note: Only part of the references are listed.Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors
Jonathan W. Bushman et al.
CELL CHEMICAL BIOLOGY (2021)
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
Tyler B. Faust et al.
NATURE CHEMICAL BIOLOGY (2020)
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem et al.
CELL (2020)
Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase
Ka Yang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
Laura Sinatra et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells
Ekaterina V. Vinogradova et al.
CELL (2020)
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Dichotomous engagement of HDAC3 activity governs inflammatory responses
Hoang C. B. Nguyen et al.
NATURE (2020)
HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation
Venkat Giri Magupalli et al.
SCIENCE (2020)
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
Monica Phimmachanh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Katherine A. Donovan et al.
CELL (2020)
Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)
Fangyuan Cao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex
Jessie Hao-Ru Hsu et al.
CELL CHEMICAL BIOLOGY (2020)
Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling
Inchul You et al.
CELL CHEMICAL BIOLOGY (2020)
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
Mei Zeng et al.
CELL CHEMICAL BIOLOGY (2020)
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs
Yufeng Xiao et al.
CHEMICAL COMMUNICATIONS (2020)
PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes
Joshua P. Smalley et al.
CHEMICAL COMMUNICATIONS (2020)
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
Alina Mares et al.
COMMUNICATIONS BIOLOGY (2020)
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
M. Catarina Silva et al.
ELIFE (2019)
Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity
Hao Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
William Farnaby et al.
NATURE CHEMICAL BIOLOGY (2019)
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders
Shang Su et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70
Liqing Luo et al.
CELL REPORTS (2019)
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
Vittoria Zoppi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Blake E. Smith et al.
NATURE COMMUNICATIONS (2019)
Developing potent PROTACs tools for selective degradation of HDAC6 protein
Zixuan An et al.
PROTEIN & CELL (2019)
Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands
Norihito Shibata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis
Mikhail M. Savitski et al.
CELL (2018)
Phthalimide conjugations for the degradation of oncogenic PI3K
Wenlu Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
Susan E. Dorman et al.
LANCET INFECTIOUS DISEASES (2018)
Peptide Level Turnover Measurements Enable the Study of Proteoform Dynamics
Jana Zecha et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Plasticity in binding confers selectivity in ligand-induced protein degradation
Radoslaw P. Nowak et al.
NATURE CHEMICAL BIOLOGY (2018)
Delineating the role of cooperativity in the design of potent PROTACs for BTK
Adelajda Zorba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera et al.
FRONTIERS IN ONCOLOGY (2018)
Epigenetic regulation of the circadian gene Per1 contributes to age-related changes in hippocampal memory
Janine L. Kwapis et al.
NATURE COMMUNICATIONS (2018)
Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome
Katherine A. Donovan et al.
ELIFE (2018)
Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation
Philipp M. Cromm et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
Quinlan L. Sievers et al.
SCIENCE (2018)
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
Hai-Tsang Huang et al.
CELL CHEMICAL BIOLOGY (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso et al.
CLINICAL CANCER RESEARCH (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
Targeted protein degradation by PROTACs
Taavi K. Neklesa et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Developing selective histone deacetylases (HDACACs) inhibitors through ebselen and analogs
Yuren Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Differential HDAC1 and 2 Recruitment by Members of the MIER Family
Roya Derwish et al.
PLOS ONE (2017)
Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
Ashton C. Lai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes
Isabelle Becher et al.
ACS CHEMICAL BIOLOGY (2014)
MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes
Graeme C. McAlister et al.
ANALYTICAL CHEMISTRY (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera et al.
NATURE CHEMICAL BIOLOGY (2013)
Histone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury
Jie Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Impact of linker length on the activity of PROTACs
Kedra Cyrus et al.
MOLECULAR BIOSYSTEMS (2011)
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2011)
Chemical phylogenetics of histone deacetylases
James E. Bradner et al.
NATURE CHEMICAL BIOLOGY (2010)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Targeting Histone Deacetylases in Neuroblastoma
O. Witt et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Multiple roles of HDAC inhibition in neurodegenerative conditions
De-Maw Chuang et al.
TRENDS IN NEUROSCIENCES (2009)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
Ashley R. Schneekloth et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Small molecules destabilize cIAP1 by activating auto-ubiquitylation
Keiko Sekine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: Multiple mechanisms of action
Hyeon Ju Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer
Sigal Gery et al.
CLINICAL CANCER RESEARCH (2007)
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Anne E. Carpenter et al.
GENOME BIOLOGY (2006)
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity:: Discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]-phenyl]-2-propenamide (NVP-LAQ824)
SW Remiszewski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Class II histone deacetylases: versatile regulators
E Verdin et al.
TRENDS IN GENETICS (2003)
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression
XJ Yang et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
Identification of novel isoform-selective inhibitors within class I histone deacetylases
ED Hu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
A fluorogenic histone deacetylase assay well suited for high-throughput activity screening
D Wegener et al.
CHEMISTRY & BIOLOGY (2003)
Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo
W Fischle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5
TA McKinsey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
